Laird Norton Wetherby Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $694K | Buy |
|
|||||
|
2024
Q4 | $519K | Buy |
|
|||||
|
2024
Q3 | $484K | Sell |
|
|||||
|
2024
Q2 | $528K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Sell |
|
|||||
|
2023
Q4 | $1.24M | Sell |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $1.68M | Sell |
|
|||||
|
2023
Q1 | $1.85M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $1.34M | Buy |
|
|||||
|
2022
Q2 | $1.26M | Sell |
|
|||||
|
2022
Q1 | $2.06M | Buy |
|
|||||
|
2021
Q4 | $980K | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $978K | Buy |
|
|||||
|
2021
Q1 | $755K | Sell |
|
|||||
|
2020
Q4 | $757K | Sell |
|
|||||
|
2020
Q3 | $995K | Buy |
|
|||||
|
2020
Q2 | $886K | Buy |
|
|||||
|
2020
Q1 | $407K | Sell |
|
|||||
|
2019
Q4 | $855K | Buy |
|
|||||
|
2019
Q3 | $595K | Buy |
|
|||||
|
2019
Q2 | $392K | Sell |
|
|||||
|
2019
Q1 | $709K | Buy |
|